Announcements Trials
Browse Landscape

Phase

Phase 2 57Phase 1 29Phase 1/2 16Phase NA 8Phase 3 7Phase EARLY_PHASE1 3Phase 4 2Phase 2/3 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1CNS 1

Conditions

Plasmacytoma 1POEMS Syndrome 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × dexamethasone acetate × Clear all
NCT04895592 2026-05-14

Radiosurgery Before Surgery for the Treatment of Brain Metastases

Emory University

Phase EARLY_PHASE1 Completed
26 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT02921893 2025-02-12

Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome

Mayo Clinic

Phase EARLY_PHASE1 Completed
21 enrolled
Plasma cell

Plasmacytoma, POEMS Syndrome

NCT01878708 2017-03-06

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Terminated
2 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡